Systematic review of the efficacy, effectiveness and safety of MF59 adjuvanted seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
O Murchu, EamonComber, Laura
Jordan, Karen
Hawkshaw, Sarah
Marshall, Liam
O'Neill, Michelle
Ryan, Máirín
Teljeur, Conor
Carnahan, Annasara
Pérez, Jaime Jesús
Robertson, Anna Hayman
Johansen, Kari
Jonge, Jorgen de
Krause, Tyra
Nicolay, Nathalie
Nohynek, Hanna
Pavlopoulou, Ioanna
Pebody, Richard
Penttinen, Pasi
Soler-Soneira, Marta
Wichmann, Ole
Harrington, Patricia
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Systematic review of the efficacy, effectiveness and safety of MF59 adjuvanted seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.Published in
Reviews in medical virology 2022;e2329DOI
10.1002/rmv.2329PMID
35142401ae974a485f413a2113503eed53cd6c53
10.1002/rmv.2329
Scopus Count
Collections
Related articles
- Comparative efficacy and safety of vaccines to prevent seasonal influenza: A systematic review and network meta-analysis.
- Authors: Minozzi S, Lytras T, Gianola S, Gonzalez-Lorenzo M, Castellini G, Galli C, Cereda D, Bonovas S, Pariani E, Moja L
- Issue date: 2022 Apr
- Comparison of the immunogenicity and safety of the conventional subunit, MF59-adjuvanted, and intradermal influenza vaccines in the elderly.
- Authors: Seo YB, Choi WS, Lee J, Song JY, Cheong HJ, Kim WJ
- Issue date: 2014 Jul
- A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration.
- Authors: Della Cioppa G, Nicolay U, Lindert K, Leroux-Roels G, Clement F, Castellino F, Galli C, Groth N, Levin Y, Del Giudice G
- Issue date: 2014
- Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults.
- Authors: Essink B, Fierro C, Rosen J, Figueroa AL, Zhang B, Verhoeven C, Edelman J, Smolenov I
- Issue date: 2020 Jan 10
- Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.
- Authors: Vesikari T, Kirstein J, Devota Go G, Leav B, Ruzycky ME, Isakov L, de Bruijn M, Oberye J, Heijnen E
- Issue date: 2018 May